Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07220200 · ClinicalTrials.gov registry record · NA
MOVE Protocol - Movement-Oriented Velocity of Engagement
A NA study of Musculoskeletal Pain - Acute and Subacute Conditions, sponsored by MMSx Authority Institute for Movement Mechanics and Biomechanics Research.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 4
- Study locations
NCT07220200: Completed NA study of Musculoskeletal Pain - Acute and Subacute Conditions, sponsored by MMSx Authority Institute for Movement Mechanics and Biomechanics Research.
NCT07220200 is a NA study of Musculoskeletal Pain - Acute and Subacute Conditions that has completed, run by MMSx Authority Institute for Movement Mechanics and Biomechanics Research. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07220200, a NA study of Musculoskeletal Pain - Acute and Subacute Conditions, has completed, sponsored by MMSx Authority Institute for Movement Mechanics and Biomechanics Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 4
- Study locations
Study Summary
A Prospective, Multi-Site, Interventional Case-Series Evaluating the MOVE (Movement-Oriented Velocity of Engagement) Protocol for Musculoskeletal Pain Recovery
Primary Outcome
Change in Numeric Rating Scale (NRS) for pain intensity from baseline to week 8 following the MOVE (Movement-Oriented Velocity of Engagement) rehabilitation program. Participants rated pain on a 0-10 scale where 0 = no pain and 10 = worst possible pain.
Conditions Studied
Interventions
- BEHAVIORAL MOVE Rehabilitation Protocol
Study Locations (4)
Ohio
- BodyGNTX Fitness Institute - Columbus
- MMSx AUTHORITY (COORDINATING CENTER) - Powell
Madhya Pradesh
- Indian Institute of Kinesiology & Biomechanics Science (IIKBS) - Burhānpur
National Capital Territory of Delhi
- GFFI Fitness Academy - New Delhi
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-06-15 |
| Est. Completion | 2025-10-17 |
| Phase | NA |
What the finished NCT07220200 record still lists
NCT07220200 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Musculoskeletal Pain - Acute and Subacute Conditions appearing as the primary indexed condition, and to 1 intervention - of which MOVE Rehabilitation Protocol is the first listed.
NCT07220200 reports a single indexed study location in Ohio, Madhya Pradesh, National Capital Territory of Delhi.
Frequently Asked Questions
What is clinical trial NCT07220200 about?
NCT07220200 is a clinical study titled "MOVE Protocol - Movement-Oriented Velocity of Engagement". A Prospective, Multi-Site, Interventional Case-Series Evaluating the MOVE (Movement-Oriented Velocity of Engagement) Protocol for Musculoskeletal Pain Recovery
What is the current status of trial NCT07220200?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2024-06-15. Estimated completion is 2025-10-17.
What conditions does trial NCT07220200 study?
This clinical trial studies the following conditions: Musculoskeletal Pain - Acute and Subacute Conditions.
What interventions are being tested in trial NCT07220200?
The interventions under investigation include: MOVE Rehabilitation Protocol (BEHAVIORAL).
Who is sponsoring clinical trial NCT07220200?
This trial is sponsored by MMSx Authority Institute for Movement Mechanics and Biomechanics Research, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07220200 being conducted?
This trial has 4 study locations across Ohio, Madhya Pradesh, National Capital Territory of Delhi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07220200's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI